CLINICAL LAB SCIENEC

466
INDEX
described, 223
serial, 403
of sample, 224–225, 224t, 225f
10-fold compound, 406, 406f
Dilution factor, defined, 223
Dilution series, two-fold, 405, 405f
Dining room workers, infection
control in, 123–124
Dipstick, urinalysis, 221, 293, 293f,
294f
testing with, described, 296
Direct blood grouping
slide method in, 424–426, 425f.
See also Immunohematology
(blood banking), direct blood
or forward grouping by slide
method
test tube method in, 422–424.
See also Immunohematology
(blood banking), direct blood
grouping by test tube method
Direct pay, 159
Director(s), of medical laboratory,
28–30, 29f
Disability(ies), persons with, requirements
for working with, 12
Discrete analysis, 365
Disposal of medical wastes and toxic
chemicals, policies for, 95–97,
96f–98f
Distance, as measurement type, 210
Distilled water, preparation of, methodology
for, 217
Division of Laboratory Services,
Center for Medicaid and
State Operations, Survey and
Certification Group of, 10
D.L.M. See Doctor of laboratory
medicine (D.L.M.)
DNA, 84
Doctor of laboratory medicine
(D.L.M.), described, 30
E
Economics
medical, laboratory equipment
and, 155–172
of medical services, 161–172. See
also Medical services, costs of
EDTA, described, 327
EDTA tubes, 327
Education, exposure-prevention, in
bloodborne- and airborne
pathogen–related infection
prevention, 151
Educational institutions, licensure of,
36–37, 36t
Educational programs, accreditation
of, 34–36, 35t
Efficiency of methodology, in QA,
261
1802 Haitian Revolution, yellow
fever during, 2
Electrochemistry, 364
Electrolyte(s)
described, 381
determination of, 381–384, 382f,
382t, 383f
equipment and supplies, 383
principles, 381–382, 382f, 382t,
383f
procedure, 383
reporting of results, 383–384
imbalances of, diabetic comas due
to, 382
measuring of, 382, 382f, 383f
normal values for, 382, 382t
End-point reaction, 364
in clinical chemistry procedures,
369, 369f
Engineered controls, 116
defined, 147
English units, conversion to metric
units, 212–213, 213t
Environmental Protection Agency
(EPA), 116
Eosinophils, 330t
EPA. See Environmental Protection
Agency (EPA)
Equipment maintenance, schedule
for, as safety issue, 106
Equivalency testing, described, 45
Equivalent weight, defined, 219–220
Erlenmeyer flasks, 188–189, 189f
Erroneous samples, 256–258
categories of, 258–259
characteristics of, 257–258
effects of position on laboratory
values, 257
types of, 257–258
Error(s)
analytical, 258–259
defined, 235t
postanalytical, 259
defined, 235t
preanalytical, 258, 366
defined, 235t
random, 237, 367
defined, 235t
systematic
defined, 236t
detection of, 244–245
Erythrocyte(s), in blood, 340
Ethics
defined, 63
of health care, 61–76
introduction to, 61–63
questions related to, 70–71
standards for, 70
professionalism and, relationship
between, 65–66
Evaporation, 281
Exposure
to airborne pathogens, phlebotomy
and, 266, 267t
to bloodborne pathogens, phlebotomy
and, 266, 267t
described, 126–127
immediate action after, 131–132
occupational, to TB, workers most
at risk for, 144, 145
potential
assessment of, 128–129, 129f
described, 126–127
to TB, described, 143–144
through spills of biohazardous
and toxic materials,
127–128
Exposure control, measures in, 5
Exposure Control Committee,
85–86, 85t, 91, 99, 116
Exposure control methods, in
protecting against biological
hazards in microbiology
laboratory, 388, 389t
Exposure Control Plan, 117
Exposure incident
described, 126–127
documentation of, 132–134
Exposure training, in infection control,
129–132
Exposure-prevention education, in
bloodborne- and airborne
Copyright 2010 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.